|Bid||151.00 x 1300|
|Ask||153.59 x 900|
|Day's range||151.46 - 153.86|
|52-week range||105.56 - 175.91|
|Beta (5Y monthly)||0.81|
|PE ratio (TTM)||22.07|
|Forward dividend & yield||5.64 (3.67%)|
|Ex-dividend date||14 July 2022|
|1y target est||N/A|
Three little words can make you a lot of money over the long term: Buy and hold. Here's why they picked AbbVie (NYSE: ABBV), Bristol Myers Squibb (NYSE: BMY), and Vertex Pharmaceuticals (NASDAQ: VRTX). Prosper Junior Bakiny (AbbVie): Pharma giant AbbVie is currently defying gravity.
A blockbuster could be on the way next year -- but if you wait that long to invest, could it be too late?
Dividend stocks aren't always known for generating sizzling gains. Here are the three best Dividend Aristocrat stocks in the first half of 2022. At its peak in early June, ExxonMobil stock was up more than 70%.